Cargando…
Early “reduction to practice” of the CRISPR–Cas9 invention in eukaryotic cells
Autor principal: | Aquino-Jarquin, Guillermo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578556/ https://www.ncbi.nlm.nih.gov/pubmed/36267416 http://dx.doi.org/10.3389/fgene.2022.1009688 |
Ejemplares similares
-
CRISPR/Cas13-Based Approaches for Ultrasensitive and Specific Detection of microRNAs
por: Granados-Riveron, Javier T., et al.
Publicado: (2021) -
Recent progress on rapid SARS-CoV-2/COVID-19 detection by CRISPR-Cas13-based platforms
por: Aquino-Jarquin, Guillermo
Publicado: (2021) -
Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021) -
Adapting CRISPR/Cas9 System for Targeting Mitochondrial Genome
por: Hussain, Syed-Rehan A., et al.
Publicado: (2021) -
CRISPR/Cas9 Application for Gene Copy Fate Survey of Polyploid Vertebrates
por: Yin, Fanqian, et al.
Publicado: (2018)